Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - NovaBay Pharmaceuticals, Inc. | ex_177277.htm |
| EX-32.1 - EXHIBIT 32.1 - NovaBay Pharmaceuticals, Inc. | ex_177278.htm |
| EX-31.2 - EXHIBIT 31.2 - NovaBay Pharmaceuticals, Inc. | ex_177279.htm |
| EX-31.1 - EXHIBIT 31.1 - NovaBay Pharmaceuticals, Inc. | ex_177280.htm |
| 10-K - FORM 10-K - NovaBay Pharmaceuticals, Inc. | nby20191231_10k.htm |
Exhibit 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in Registration Statements on Form S-8 (File Nos. 333-236328, 333-222625, 333-218469, 333-215680, 333-211754, 333-208985, 333-203109, 333-196764, 333-194383, 333-185998, 333-180461, 333-171981, 333-147334, 333-157041, and 333-164469), Form S-3 (File Nos. 333-233623, 333-232860, 333-230672, 333-211944 and 333-211943) and Form S-1 (File No. 333-234330) of NovaBay Pharmaceuticals, Inc. of our report dated March 26, 2020 (which report expresses an unqualified opinion and includes an explanatory paragraph related to substantial doubt about the Company’s ability to continue as a going concern), relating to the consolidated financial statements of NovaBay Pharmaceuticals, Inc., which appears in this Annual Report on Form 10-K.
/s/ OUM & CO. LLP
San Francisco, California
March 26, 2020